T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.18% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 14.24% |
| 4 | Technology | 12.89% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Steel Dynamics
STLD
$37.2B
| $3.02M | ﹤0.01% |
123,366
-719,859
| -85% | -$17.6M |
|
1452
Lear
LEA
$8.25B
| $3M | ﹤0.01% |
29,429
+2,806
| +11% | +$315K |
|
1453
Glaukos
GKOS
$11.1B
| $2.98M | ﹤0.01% |
102,028
+66,687
| +189% | +$1.54M |
|
1454
Everest Group
EG
$14.1B
| $2.97M | ﹤0.01% |
16,246
+437
| +3% | +$80.3K |
|
1455
UGI
UGI
$7.61B
| $2.95M | ﹤0.01% |
65,195
-6,876
| -10% | -$290K |
|
|
FLG
1456
Flagstar Bank National Association
FLG
$5.93B
| $2.89M | ﹤0.01% |
64,258
+7,098
| +12% | +$323K |
|
1457
Hilltop Holdings
HTH
$2.28B
| $2.85M | ﹤0.01% |
135,898
+30,700
| +29% | +$613K |
|
1458
AXIS Capital
AXS
$7.37B
| $2.81M | ﹤0.01% |
51,145
-3,808
| -7% | -$207K |
|
|
PBPB
1459
DELISTED
Potbelly
PBPB
| $2.81M | ﹤0.01% |
224,085
-7,260
| -3% | -$96.7K |
|
|
Y
1460
DELISTED
Alleghany Corp
Y
| $2.8M | ﹤0.01% |
5,090
-603
| -11% | -$314K |
|
1461
TriplePoint Venture Growth BDC
TPVG
$219M
| $2.79M | ﹤0.01% |
263,581
-244,890
| -48% | -$2.58M |
|
1462
Box
BOX
$4.56B
| $2.77M | ﹤0.01% |
267,485
-13,606
| -5% | -$163K |
|
1463
Essential Utilities
WTRG
$11.4B
| $2.73M | ﹤0.01% |
76,417
+31
| +0% | +$1.01K |
|
1464
Enerpac Tool Group
EPAC
$1.88B
| $2.7M | ﹤0.01% |
119,250
-10,600
| -8% | -$272K |
|
|
AGTC
1465
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.68M | ﹤0.01% |
189,981
| – | – |
|
1466
News Corp Class B
NWS
$17.9B
| $2.63M | ﹤0.01% |
225,200
-8,510
| -4% | -$106K |
|
1467
Arista Networks
ANET
$251B
| $2.62M | ﹤0.01% |
651,856
+308,944
| +90% | +$1.31M |
|
1468
SEI Investments
SEIC
$12.8B
| $2.59M | ﹤0.01% |
53,808
+4,763
| +10% | +$229K |
|
1469
Gran Tierra Energy
GTE
$332M
| $2.56M | ﹤0.01% |
75,766
+560
| +0.7% | +$16.2K |
|
1470
Ameris Bancorp
ABCB
$6.03B
| $2.55M | ﹤0.01% |
85,980
+30,900
| +56% | +$944K |
|
|
CIT
1471
DELISTED
CIT Group Inc.
CIT
| $2.54M | ﹤0.01% |
79,547
+6,882
| +9% | +$224K |
|
1472
Wolfspeed
WOLF
$1.58B
| $2.51M | ﹤0.01% |
102,801
+9,720
| +10% | +$236K |
|
|
VAL
1473
DELISTED
Valspar
VAL
| $2.51M | ﹤0.01% |
23,253
-243,778
| -91% | -$26.2M |
|
1474
Targa Resources
TRGP
$58.7B
| $2.5M | ﹤0.01% |
59,302
+2,410
| +4% | +$94.4K |
|
1475
Franklin Electric
FELE
$4.68B
| $2.5M | ﹤0.01% |
75,520
-3,400
| -4% | -$111K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.